RxDoctor Payments DataLook up a doctor →

Bryan Mehlhaff, MD

Urology · Springfield, ORNPI 1518978204

Payments from drug & device makers

$10,439,842in general payments, 2019–2025

Across 2,013 payments — averaging $5186.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medivation LLC.$4M
  • Pfizer$1.9M
  • Janssen Research & Development, LLC$1.2M
  • Novartis$1M
  • Merck$589K
  • Dendreon Pharmaceuticals LLC$479K
  • plus $1.2M from 35 others
$42,656in research payments, 2019–2025

Across 9 payments — averaging $4739.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dendreon Pharmaceuticals LLC$31K
  • Pfizer$6K
  • Eli Lilly$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,439,842 in reported general payments places this provider in the 95th percentile of 153 urology providers in Oregon.

See all urology providers in Oregon

Medicare billing

Part B allowed, 2024
$279,285
Medicare patients
376
Services billed
9,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →